JP7877300B2 - 全身性コルチコステロイドによる治療を受けているcopd患者におけるウイルス誘導性増悪を治療するための吸入インターフェロン-ベータの使用 - Google Patents
全身性コルチコステロイドによる治療を受けているcopd患者におけるウイルス誘導性増悪を治療するための吸入インターフェロン-ベータの使用Info
- Publication number
- JP7877300B2 JP7877300B2 JP2023515363A JP2023515363A JP7877300B2 JP 7877300 B2 JP7877300 B2 JP 7877300B2 JP 2023515363 A JP2023515363 A JP 2023515363A JP 2023515363 A JP2023515363 A JP 2023515363A JP 7877300 B2 JP7877300 B2 JP 7877300B2
- Authority
- JP
- Japan
- Prior art keywords
- ifn
- copd
- patients
- administration
- pharmaceutical preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A61K38/215—IFN-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2014114.9 | 2020-09-08 | ||
| GBGB2014114.9A GB202014114D0 (en) | 2020-09-08 | 2020-09-08 | Use of inhaled interferon-beta to treat virus-induced exacerbations in copd patients undergoing treatment with a systemic corticosteroid |
| PCT/GB2021/052302 WO2022053792A1 (en) | 2020-09-08 | 2021-09-07 | Use of inhaled interferon-beta to treat virus-induced exacerbations in copd patients undergoing treatment with a systemic corticosteroid |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023540591A JP2023540591A (ja) | 2023-09-25 |
| JP2023540591A5 JP2023540591A5 (cg-RX-API-DMAC7.html) | 2024-09-13 |
| JP7877300B2 true JP7877300B2 (ja) | 2026-06-22 |
Family
ID=72841287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023515363A Active JP7877300B2 (ja) | 2020-09-08 | 2021-09-07 | 全身性コルチコステロイドによる治療を受けているcopd患者におけるウイルス誘導性増悪を治療するための吸入インターフェロン-ベータの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230241177A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4210728A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7877300B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230066037A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116249545A (cg-RX-API-DMAC7.html) |
| GB (1) | GB202014114D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022053792A1 (cg-RX-API-DMAC7.html) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007528890A (ja) | 2004-03-12 | 2007-10-18 | ユニバーシティ、オブ、サウサンプトン | 呼吸器疾患の抗ウイルス療法のためのインターフェロン−β |
| JP2012512883A (ja) | 2008-12-19 | 2012-06-07 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | ウイルス感染の治療における上皮成長因子阻害剤の使用 |
| JP2013522282A (ja) | 2010-03-12 | 2013-06-13 | シナーゲン リサーチ リミティッド | インフルエンザ様疾患の治療 |
| WO2020128473A1 (en) | 2018-12-19 | 2020-06-25 | Imperial College Innovations Limited | Novel compounds and their use in therapy |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6030609A (en) | 1995-05-19 | 2000-02-29 | Case Western Reserve University | Method and composition for treating paramyxovirus |
| US7871603B2 (en) | 2007-05-18 | 2011-01-18 | Synairgen Research Limited | Interferon-beta and/or lambda for use in treating rhinovirus infection in the elderly |
| WO2015157955A1 (en) * | 2014-04-17 | 2015-10-22 | Abbvie Inc. | Heterocyclic btk inhibit ors |
-
2020
- 2020-09-08 GB GBGB2014114.9A patent/GB202014114D0/en not_active Ceased
-
2021
- 2021-09-07 CN CN202180061630.8A patent/CN116249545A/zh active Pending
- 2021-09-07 JP JP2023515363A patent/JP7877300B2/ja active Active
- 2021-09-07 EP EP21777826.5A patent/EP4210728A1/en active Pending
- 2021-09-07 KR KR1020237011584A patent/KR20230066037A/ko active Pending
- 2021-09-07 US US18/024,648 patent/US20230241177A1/en active Pending
- 2021-09-07 WO PCT/GB2021/052302 patent/WO2022053792A1/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007528890A (ja) | 2004-03-12 | 2007-10-18 | ユニバーシティ、オブ、サウサンプトン | 呼吸器疾患の抗ウイルス療法のためのインターフェロン−β |
| JP2012512883A (ja) | 2008-12-19 | 2012-06-07 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | ウイルス感染の治療における上皮成長因子阻害剤の使用 |
| JP2013522282A (ja) | 2010-03-12 | 2013-06-13 | シナーゲン リサーチ リミティッド | インフルエンザ様疾患の治療 |
| WO2020128473A1 (en) | 2018-12-19 | 2020-06-25 | Imperial College Innovations Limited | Novel compounds and their use in therapy |
Non-Patent Citations (1)
| Title |
|---|
| Lancet,2015年,385(Suppl.1),S88, Poster52,https://www.thelancet.com/action/showPdf?pii=S0140-6736%2815%2960403-2 |
Also Published As
| Publication number | Publication date |
|---|---|
| EP4210728A1 (en) | 2023-07-19 |
| US20230241177A1 (en) | 2023-08-03 |
| GB202014114D0 (en) | 2020-10-21 |
| JP2023540591A (ja) | 2023-09-25 |
| WO2022053792A1 (en) | 2022-03-17 |
| KR20230066037A (ko) | 2023-05-12 |
| CN116249545A (zh) | 2023-06-09 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240905 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240905 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20250820 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250826 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20251120 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20260512 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20260610 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7877300 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |